Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

Share Price is delayed by 15 minutes
Get Live Data
585.00    0.00 (0.00%)
Bid:
580.00
Ask:
590.00
Spread: 10.00 (1.724%)
Market Cap: £239.51m
SAG Live PriceLast checked at - London Stock Exchange

Intraday Science Group Share Chart

Form 8.3 - Science Group Plc

24 Sep 2018 17:02

Miton Asset Management Limited - Form 8.3 - Science Group Plc

Miton Asset Management Limited - Form 8.3 - Science Group Plc

PR Newswire

London, September 24

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:LF MITON UK VALUE OPPORTUNITIES FUND
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. MITON GROUP PLC
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree SCIENCE GROUP PLC
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 24/09/2018
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A” NO

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled: 1,943,359 4.86%
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL: 1,943,359 4.86%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
NONE

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure: 24/09/2018
Contact name: GEORGE LATIMER-BUTER
Telephone number: 0203 714 1486

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
31st Oct 20227:00 amRNSRecommended Cash Aquisition of TP Group plc
12th Oct 20224:55 pmRNSTreasury shares issued
30th Sep 20224:35 pmRNSTotal Voting Rights
28th Sep 20227:00 amRNSIssue of share options and PDMR dealing
21st Sep 20223:59 pmRNSTreasury shares issued
2nd Sep 20225:37 pmRNSTransaction in Own Shares
2nd Sep 20227:00 amRNSTransaction in Own Shares
1st Sep 20227:00 amRNSTotal Voting Rights
26th Aug 20225:47 pmRNSTransaction in Own Shares
10th Aug 20227:00 amRNSTransaction in Own Shares
9th Aug 20227:00 amRNSTransaction in Own Shares
2nd Aug 20225:18 pmRNSTransaction in Own Shares
29th Jul 20225:41 pmRNSTransaction in Own Shares
28th Jul 20225:53 pmRNSTransaction in Own Shares
27th Jul 20225:31 pmRNSTransaction in Own Shares
27th Jul 20223:24 pmRNSHolding(s) in Company
27th Jul 20227:00 amRNSTransaction in Own Shares
25th Jul 20227:00 amRNSInterim results for 6 months ended 30 June 2022
22nd Jul 20227:00 amRNSNotice of Interim Results
31st May 20224:40 pmRNSTotal Voting Rights
24th May 20225:31 pmRNSTransaction in Own Shares
23rd May 20225:15 pmRNSTransaction in Own Shares
19th May 20225:39 pmRNSHolding(s) in Company
19th May 20225:37 pmRNSHolding(s) in Company
18th May 20225:50 pmRNSTransaction in Own Shares
18th May 20221:17 pmRNSResult of AGM
18th May 20227:00 amRNSAGM Trading Update and NED Appointment
10th May 20224:45 pmRNSTreasury shares issued
29th Apr 20224:45 pmRNSTotal Voting Rights
12th Apr 20227:00 amRNSPosting of AGM documents & Notice of AGM
7th Apr 20227:23 amRNSTransaction in Own Shares
5th Apr 20225:30 pmRNSTransaction in Own Shares
4th Apr 20226:00 pmRNSTransaction in Own Shares
1st Apr 20225:30 pmRNSTransaction in Own Shares
1st Apr 20227:00 amRNSTransaction in Own Shares & Total Voting Rights
30th Mar 20225:20 pmRNSTransaction in Own Shares
29th Mar 20225:30 pmRNSTransaction in Own Shares
28th Mar 20225:10 pmRNSTransaction in Own Shares
25th Mar 20225:15 pmRNSTransaction in Own Shares
25th Mar 20227:00 amRNSTransaction in Own Shares
23rd Mar 20224:55 pmRNSTransaction in Own Shares
22nd Mar 20226:15 pmRNSTransaction in Own Shares
21st Mar 20225:25 pmRNSTransaction in Own Shares
18th Mar 20225:10 pmRNSTransaction in Own Shares
17th Mar 20225:20 pmRNSTransaction in Own Shares
17th Mar 20227:00 amRNSTransaction in Own Shares
16th Mar 20227:00 amRNSAudited Results for year ended 31 December 2021
14th Mar 202211:00 amRNSNotice of Preliminary Results
7th Feb 20227:00 amRNSDirector update
13th Jan 20227:00 amRNS2021 End of Year Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.